Is this what you we're talking about ? GLTA

Is this what you we're talking about ? GLTA

QUOTE:




Todd Hughes

14 hrs
..

Before I start, keep in mind this is all my OPINION based upon some facts & a lot of gut feelings. Please don't take my word for anything & VERIFY everything I say. It's your money you've invested, not mine. No one's going to replace your losses & no one's going to replace my losses. Always verify everything.

The other day, I said that the 750,000,000 authorized shares for Incumaker spoke volumes about what lies ahead for us. If you've been reading all the posts on this board & following the 3+ year saga of this stock, then you may already know what I'm about to say. We all know that we were spun off to be a stand alone company & are now in the process of being acquired in a merger by Eastern Starr Biotech, Inc. The PR on Thursday stated the Certificate of Amendment had been submitted to the Delaware Secretary of State. Based upon the links I'm adding to the comments sections, it can typically take 10-15 business days (2-3 weeks) & up to 3-4 weeks to process during the months of March, June & December. However, it can be expedited within 24 hours for a $100 expedite fee. I'm not sure if that's total or per page though. Based upon the document, it appears there's just a cover letter & the filled out document only. I couldn't find where they would have to submit more than those two pages, but they might have to. In any event, it can take anywhere from 1 day to 4 weeks to get this phase done. Then, it goes to the SEC to have the shares registered & that can take from 1-4 weeks to complete. After all of this, the assets of Cen Biotech have to be turned over to ESB & the shares disbursed as of the Record Date. So, it looks like shares will be in our accounts sometime between one week and as much as two months from now. We're almost there folks.

The 10K told us that all of the assets/liabilities of Cen Biotech & all the current 10,525,000 shares (they'll be retired) were being acquired by Eastern Starr Biotech in this merger. I, like many others, assumed Cen Ukraine was a part of it, but Bill clarified that Cen Ukraine was independent & had to be acquired first. When I asked if it was being negotiated on currently, he responded "No comment. But, I can tell you it was recently audited".

So, that means the only real value at first will be T-Cen. Ryan Rottier posted a document a couple of weeks ago that showed the value of Cen Biotech at $49,000,000. Currently, Incumaker has two subsidiaries, Cryomist & Real Deal Recruits. It looks like Cryomist was shut down & their assets retained by the investor that had invested the money to launch the Cryomist clinic. But, I haven't had a chance to dig into the particulars of Cryomist yet. Real Deal Recruits is still active, but has produced no revenue since Incumaker paid $50,000 for a 20% ownership in it in May of 2015. The revenue was expected to come from advertising & registration fees. Incumaker shows zero assets & $586,030 in liabilities (mostly covered by restricted shares). So, for all practical purposes, Eastern Starr Biotech is all the value Incumaker will have once the merger is complete. Incumaker currently shows just over 22 million outstanding shares out of 75 million authorized shares. That means they currently have about 58 million shares to use for acquisitions, in exchange for capital & for services rendered such as legal expenses, accounting, etc. etc.

Now, about that 750 million shares. I've been waiting to see just how many shares they were going to get authorized as a sign of further acquisitions beyond Cen Biotech. With just over 22 million shares already released, that leaves about 728 million shares available for acquisitions, raising capital & paying for services. We know that 100 million of those shares are being used to acquire Cen Biotech. That leaves 628 million shares left. Bill said that Cen Ukraine has to be acquired & has recently been audited. You don't usually get a non trading company audited, unless you plan on selling it or using the value to borrow money. I've seen the price of audits run from $40k to $75K. They're not cheap. My theory is that once the merger is complete with ESB, we will then acquire Cen Ukraine with some of the 628 million shares shortly thereafter. Thus, adding the value of Cen Ukraine to the alleged $49 million current value of Cen Biotech. That should push the PPS up to match the value added from Cen Ukraine. I'm also hoping that the shares to acquire Cen Ukraine will be restricted for at least one year. That would keep the float down while adding what I hope is some significant value to ESB & driving the PPS up significantly. But, I'm not sure if they will be restricted or not.

I very seriously doubt that Cen Ukraine will eat up the full 628 million shares, so that opens us up for further acquisitions & more value to be added to ESB. In the 10K, it indicates that the lease for 20 North Rear Road was closed & a NEW lease was signed. We no longer own the buildings on that site, but are now leasing them from the landlord like you would lease an office building. I posted a thread that fully explains the details of the new lease on this board if you want to see the details. So, why would we decide to sign a new lease on a place where we were denied a MMPR license from Health Canada? I asked Bill if it was possible that we might attempt to acquire an existing LP in Canada or some other company in the US. His response was "Everything is on the table". So, my next theory is that we are going to attempt to buy an existing LP & then file the necessary forms to expand that business by using the existing Lakeshore facility. With full legalization coming in 2018, acquiring an existing LP & expanding it's operations by using the Lakeshore facility before the end of the year would put us in a prime position to hit the ground running when full legalization takes effect. Thus, we'll need some of those 628 million shares to buy an existing LP. That would have the potential of adding some very significant value to ESB.

Are you getting excited yet?

There's also the pictures Bill showed us of a canning operation where he said "Something's brewing". What's that all about? When I asked Bill if it was part of us or Cen Ukraine & could he tell us what was in the cans, he simply said "Nope". So, that is another possible acquisition at some point. We also know he's been going to several other countries over the last couple of years, but we have no idea what else he & Joe might have up their sleeves.
Finally, I still believe the plan is to uplist us to the OTCQB & then to the NYSEMKT exchange at some point after that. Bill has said repeatedly that this will be EPIC & the ultimate mic drop. I believe we're going to see one PR after the other once this merger is completed. They didn't authorize that many extra shares on a whim. It was done so they could add immediate value to this stock. These are some of the reasons why I think the 750 million shares speaks volumes about what lies ahead of us. Who knows what's planned that we haven't even been given a clue about yet? Eastern Starr Biotech is going to be EPIC!!! In my opinion, of course.